Literature DB >> 28589261

Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.

Adriana Moro1, Renato P Munhoz2, Mariana Moscovich3, Walter O Arruda3, Salmo Raskin4, Laura Silveira-Moriyama5, Tetsuo Ashizawa6, Hélio A G Teive3.   

Abstract

Nonmotor symptoms (NMS) have been described in several neurodegenerative diseases but have not been systematically evaluated in spinocerebellar ataxia type 10 (SCA10). The objective of the study is to compare the frequency of NMS in patients with SCA10, Machado-Joseph disease (MJD), and healthy controls. Twenty-eight SCA10, 28 MJD, and 28 healthy subjects were prospectively assessed using validated screening tools for chronic pain, autonomic symptoms, fatigue, sleep disturbances, psychiatric disorders, and cognitive function. Chronic pain was present with similar prevalence among SCA10 patients and healthy controls but was more frequent in MJD. Similarly, autonomic symptoms were found in SCA10 in the same proportion of healthy individuals, while the MJD group had higher frequencies. Restless legs syndrome and REM sleep behavior disorder were uncommon in SCA10. The mean scores of excessive daytime sleepiness were worse in the SCA10 group. Scores of fatigue were higher in the SCA10 sample compared to healthy individuals, but better than in the MJD. Psychiatric disorders were generally more prevalent in both spinocerebellar ataxias than among healthy controls. The cognitive performance of healthy controls was better compared with SCA10 patients and MJD, which showed the worst scores. Although NMS were present among SCA10 patients in a higher proportion compared to healthy controls, they were more frequent and severe in MJD. In spite of these comparisons, we were able to identify NMS with significant functional impact in patients with SCA10, indicating the need for their systematic screening aiming at optimal treatment and improvement in quality of life.

Entities:  

Keywords:  Machado-Joseph disease; Nonmotor symptoms; Spinocerebellar ataxia type 10; Spinocerebellar ataxia type 3

Mesh:

Year:  2017        PMID: 28589261      PMCID: PMC5718954          DOI: 10.1007/s12311-017-0869-2

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  28 in total

1.  [Suggestions for utilization of the mini-mental state examination in Brazil].

Authors:  Sonia M D Brucki; Ricardo Nitrini; Paulo Caramelli; Paulo H F Bertolucci; Ivan H Okamoto
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

2.  Autonomic dysfunction in Machado-Joseph disease.

Authors:  Tu-Hsueh Yeh; Chin-Song Lu; Yah-Huei Wu Chou; Chok-Chean Chong; Tony Wu; Nai-Hui Han; Rou-Shayn Chen
Journal:  Arch Neurol       Date:  2005-04

3.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

4.  Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10.

Authors:  T Matsuura; T Yamagata; D L Burgess; A Rasmussen; R P Grewal; K Watase; M Khajavi; A E McCall; C F Davis; L Zu; M Achari; S M Pulst; E Alonso; J L Noebels; D L Nelson; H Y Zoghbi; T Ashizawa
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

5.  [Multiple sclerosis: cross-cultural adaptation and validation of the modified fatigue impact scale].

Authors:  Karina Pavan; Kizi Schmidt; Bruna Marangoni; Maria Fernanda Mendes; Charles Peter Tilbery; Sergio Lianza
Journal:  Arq Neuropsiquiatr       Date:  2007-09       Impact factor: 1.420

6.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

7.  Chronic pain in Machado-Joseph disease: a frequent and disabling symptom.

Authors:  Marcondes C França; Anelyssa D'Abreu; Joseph H Friedman; Anamarli Nucci; Iscia Lopes-Cendes
Journal:  Arch Neurol       Date:  2007-12

Review 8.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

9.  Pain in Parkinson's disease.

Authors:  C G Goetz; C M Tanner; M Levy; R S Wilson; D C Garron
Journal:  Mov Disord       Date:  1986       Impact factor: 10.338

10.  Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes.

Authors:  Raphael Machado de Castilhos; Gabriel Vasata Furtado; Tailise Conte Gheno; Paola Schaeffer; Aline Russo; Orlando Barsottini; José Luiz Pedroso; Diego Z Salarini; Fernando Regla Vargas; Maria Angélica de Faria Domingues de Lima; Clécio Godeiro; Luiz Carlos Santana-da-Silva; Maria Betânia Pereira Toralles; Silvana Santos; Hélio van der Linden; Hector Yuri Wanderley; Paula Frassineti Vanconcelos de Medeiros; Eliana Ternes Pereira; Erlane Ribeiro; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

View more
  10 in total

1.  Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2).

Authors:  Alessandra Zanatta; Carlos Henrique Ferreira Camargo; Francisco Manoel Branco Germiniani; Salmo Raskin; Ana Chrystina de Souza Crippa; Hélio Afonso Ghizoni Teive
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

Review 2.  Sleep Disorders in Hereditary Ataxias.

Authors:  Lucio Huebra; Fernando Morgadinho Coelho; Flávio Moura Rezende Filho; Orlando G Barsottini; José Luiz Pedroso
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-25       Impact factor: 5.081

3.  Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families.

Authors:  Bernardo Machado Dias Domingues; Fábio A Nascimento; Alex Tiburtino Meira; Adriana Moro; Salmo Raskin; Tetsuo Ashizawa; Hélio Afonso Ghizoni Teive
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

Review 4.  Neuroradiological Findings in the Spinocerebellar Ataxias.

Authors:  Alex Tiburtino Meira; Walter Oleschko Arruda; Sergio Eiji Ono; Arnolfo de Carvalho Neto; Salmo Raskin; Carlos Henrique F Camargo; Hélio Afonso G Teive
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-09-26

Review 5.  Nonmotor symptoms in spinocerebellar ataxias (SCAs).

Authors:  Adriana Moro; Mariana Moscovich; Marina Farah; Carlos Henrique F Camargo; Hélio A G Teive; Renato P Munhoz
Journal:  Cerebellum Ataxias       Date:  2019-08-27

Review 6.  KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes.

Authors:  Luca Pollini; Serena Galosi; Manuela Tolve; Caterina Caputi; Carla Carducci; Antonio Angeloni; Vincenzo Leuzzi
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

7.  Establish a Nomogram to Predict Falls in Spinocerebellar Ataxia Type 3.

Authors:  Junyu Lin; Lingyu Zhang; Bei Cao; Qianqian Wei; Ruwei Ou; Yanbing Hou; Xinran Xu; Kuncheng Liu; Xiaojing Gu; Huifang Shang
Journal:  Front Neurol       Date:  2021-01-27       Impact factor: 4.003

Review 8.  Cognitive Dysfunction in Repeat Expansion Diseases: A Review.

Authors:  Sizhe Zhang; Lu Shen; Bin Jiao
Journal:  Front Aging Neurosci       Date:  2022-04-11       Impact factor: 5.750

9.  ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10.

Authors:  C Alejandra Morato Torres; Faria Zafar; Yu-Chih Tsai; Jocelyn Palafox Vazquez; Michael D Gallagher; Ian McLaughlin; Karl Hong; Jill Lai; Joyce Lee; Amanda Chirino-Perez; Angel Omar Romero-Molina; Francisco Torres; Juan Fernandez-Ruiz; Tetsuo Ashizawa; Janet Ziegle; Francisco Javier Jiménez Gil; Birgitt Schüle
Journal:  HGG Adv       Date:  2022-08-15

10.  Autonomic dysfunction as the initial presentation in spinocerebellar ataxia type 3: A case report and review of the literature.

Authors:  Yi Jin; Yuchao Chen; Dan Li; Mengqiu Qiu; Menglu Zhou; Zhouyao Hu; Qiusi Cai; Xulin Weng; Xiaodong Lu; Bin Wu
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.